Data / Form D filings / DemeRx, Inc.
DemeRx, Inc.: Form D filings
DemeRx, Inc., a pharmaceuticals company in Fort Lauderdale, FL, filed 6 Form D notices with the SEC between 2010 and 2015. The latest, on May 8, 2015, reports $289,569 sold of a $499,998 offering to 9 investors.
Find out what DemeRx, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 305 South Andrews Ave, Suite 515, Fort Lauderdale, FL, 33301
- Phone
- (954) 607-3670
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Florida
- Year incorporated
- 2010
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1489594
The full lists. Form D filings in Florida: 2,702 rows, $107.02, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 8, 2015 | New notice | $499,998 | $289,569 | $210,429 | 9 | Apr 14, 2015 | sec.gov |
| Mar 1, 2013 | Amendment | $11,000,000 | $5,137,028 | $5,862,972 | 35 | Sep 19, 2012 | sec.gov |
| Feb 27, 2013 | Amendment | $11,000,000 | $5,137,028 | $5,862,972 | 35 | Sep 19, 2012 | sec.gov |
| Sep 4, 2012 | New notice | $8,250,000 | $0 | $8,250,000 | 0 | Yet to occur | sec.gov |
| Jun 21, 2010 | New notice | $15,000,000 | $0 | $15,000,000 | 0 | Yet to occur | sec.gov |
| May 3, 2010 | New notice | Indefinite | $85 | Indefinite | 5 | Apr 19, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Henry L. Mellon | Director | |
| Holger L. Weis | Executive Officer | |
| Jeffrey L. Raney | Executive Officer | |
| Charles L. Koob | Director | |
| Bruce L. Hack | Director | |
| Peter L. Nejes | Director | |
| Steve L. Gorlin | Director | |
| Skip L. Clemmons | Director |
Other pharmaceuticals companies in Florida that filed recently
- GOA Therapeutics Corp $300,000 · Nov 5, 2026
- DalCor Pharmaceuticals US, LLC $7 million · Aug 28, 2026
Every Form D from the week of May 4, 2015 · All recent filings in Florida · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what DemeRx, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.